TSE:CXR Concordia International (CXR) Stock Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free CXR Stock Alerts Add Compare Share Share Today's Range N/A50-Day RangeC$25.04▼C$25.0452-Week Range N/AVolume73,541 shsAverage Volume4,054 shsMarket CapitalizationC$1.22 billionP/E Ratio0.07Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Concordia International alerts: Email Address Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About Concordia International Stock (TSE:CXR)Concordia International Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates through two segments, Concordia International and Concordia North America. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies. This segment's products include Macrobid/Macrodantin to treat bladder infections, such as cystitis and urinary tract infections; Tetroxin drug for severe hypothyroid states; Eltroxin, levothyroxine sodium that treats patients with an underactive thyroid gland; and Fucithalmic, a topical gel treatment for patients suffering with a bacterial infection of the surface lining of the front of the eye. The Concordia North America segment provides Donnatalm, which is used as adjunctive therapy for irritable bowel syndrome; Zonegran, an anti-seizure drug indicated for adjunctive therapy in the treatment of partial seizures in adults with epilepsy; and Plaquenil and Plaquenil AG to treat rheumatoid arthritis and manage the complications of lupus, as well as suppress acute attacks from certain strains of malaria. This segment also offers photodynamic therapy with Photofrin for the treatment of certain forms of cancer that combines a photosensitizing agent with a specific type of laser that emits an exact wavelength of light and power to target cancer cells. The company sells its products through direct sales and local partnerships. The company was formerly known as Concordia Healthcare Corp. and changed its name to Concordia International Corp. in 2016. Concordia International Corp. is headquartered in Oakville, Canada.Read More Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. CXR Stock News HeadlinesMarch 27, 2024 | msn.comConcordia Studio Announces Filmmaker Fellows For 2024November 4, 2023 | msn.comOver a hundred local high school students visit Concordia College for entrepreneurship seminarApril 25, 2024 | InvestorPlace (Ad)The Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.October 24, 2023 | msn.comConcordia says Quebec's tuition plan will cost it 'tens of millions of dollars'May 17, 2023 | sports.yahoo.comConcordia Studio Selects Its 2023 Fellowship ClassApril 23, 2023 | fool.caWhy Concordia International Corp. Has Fallen +28% IntradayMarch 17, 2023 | news.yahoo.comConcordia University Wisconsin closed its Appleton, Madison and Milwaukee centers. Here's why.January 17, 2023 | msn.comAugustana provost named president of Concordia College in MinnesotaApril 25, 2024 | InvestorPlace (Ad)The Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.October 8, 2022 | msn.comHomestead girls, Concordia boys clinch cross country sectional titlesSeptember 9, 2022 | msn.comNo. 11 Concordia Prep football holds No. 3 McDonogh scoreless in second half in 26-7 upsetAugust 8, 2022 | msn.comColfax man arrested for sending explicit photos to Concordia minorJune 8, 2022 | msn.comDenham Springs man accused of asking Concordia minor for lewd photos, videosMay 21, 2022 | msn.comConcordia University Is Now Offering A Course On Kendrick LamarOctober 27, 2021 | finance.yahoo.comMorning News Call - Canada, March 15See More Headlines Receive CXR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Concordia International and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:CXR CUSIPN/A CIKN/A Webconcordiarx.com Phone+1-905-8425150FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio0.07 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio457.02 Current Ratio2.10 Quick Ratio1.66 Sales & Book Value Annual SalesC$569.62 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow5.85 Book ValueC$6.08 per share Price / BookN/AMiscellaneous Outstanding Shares48,913,000Free FloatN/AMarket CapC$1.22 billion OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Graeme Neville Duncan (Age 44)CEO & Director Mr. Karl Ian BelkChief Operations OfficerMr. Adeel Ahmad (Age 44)Chief Financial Officer Mr. Adam PeelerVP of Investor Relations & CommunicationsMr. Robert SullyGen. CounselKey CompetitorsFennec PharmaceuticalsTSE:FRXProMetic Life SciencesTSE:PLITrillium TherapeuticsTSE:TRILBELLUS HealthTSE:BLUdentalcorpTSE:DNTLView All Competitors CXR Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Concordia International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Concordia International investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), (CXRX) (CXRX), Wheaton Precious Metals (WPM), Rogers Communications (RCI) and Open Text (OTEX). How do I buy shares of Concordia International? Shares of CXR stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:CXR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Concordia International Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.